DBS TaT in Peer-assisted Telemedicine for Hepatitis C

Launched by OREGON HEALTH AND SCIENCE UNIVERSITY · May 7, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help people with Hepatitis C start their treatment. Researchers want to see if a method called Dried Blood Spot Test and Treat (DBS TaT) is better at getting people to begin treatment compared to the usual approach, which involves a blood draw in a clinic. The DBS TaT method allows for testing at home using a simple kit, and it helps identify patients who are unlikely to have serious liver damage, allowing them to start treatment sooner.

To be part of this study, participants should have an active Hepatitis C infection and be willing to take part in the PATHS program for care. Unfortunately, if someone is currently pregnant, they won't be able to join. If you decide to participate, you can expect support throughout the process as researchers work to improve how people with Hepatitis C receive treatment. This trial is currently recruiting patients aged 65 to 74, and both men and women are welcome to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Active hepatitis C infection
• • Willing to engaged with the PATHS program for clinical care
• Exclusion Criteria:
• • • Currently pregnant